C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 245/08 (2006.01) A61K 31/575 (2006.01) A61P 1/12 (2006.01) C07J 9/00 (2006.01)
Patent
CA 2691716
Provided herein are compounds, compositions and methods for decreasing NFkB DNA-binding activity in a patient comprising administering of a therapeutically effective amount of a compound or composition of the application to the patient to reduce, alleviate or treat various gastrointestinal diseases, such as inflammatory bowel disease (IBD).
L'invention porte sur des composés, des compositions et des procédés pour diminuer l'activité de liaison à NFkB ADN dans un patient, comprenant l'administration d'une quantité thérapeutiquement efficace d'un composé ou d'une composition de l'application au patient pour réduire, soulager ou traiter diverses maladies gastro-intestinales, telles que la maladie intestinale inflammatoire (IBD).
Gilmer John Francis
Kelleher Dermot
Marquez Juan Francisco
Gowling Lafleur Henderson Llp
The Provost Fellows And Scholars Of The College Of The Holy And Near Dublin
LandOfFree
Targeting diazo prodrugs for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeting diazo prodrugs for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeting diazo prodrugs for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2043733